Legal & General Group PLC Soma Logic, Inc. Transaction History

Legal & General Group PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	BUY	$1.76 - $2.83 $16,492 - $26,519	9,371 Added 6.52%	153,183 $387,000
Q3 2023 Nov 14, 2023	BUY	$1.99 - $2.45 $41,600 - $51,217	20,905 Added 17.01%	143,812 $343,000
Q2 2023 Aug 14, 2023	BUY	$2.1 - $3.36 $141,088 - $225,741	67,185 Added 120.57%	122,907 $283,000
Q1 2023 May 15, 2023	BUY	$2.13 - $3.6 $8,788 - $14,853	4,126 Added 8.0%	55,722 $142,000
Q4 2022 Feb 14, 2023	BUY	$2.05 - $3.47 $6,115 - $10,351	2,983 Added 6.14%	51,596 $129,000
Q3 2022 Nov 14, 2022	BUY	$0.63 - $5.47 $856 - $7,433	1,359 Added 2.88%	48,613 $141,000
Q2 2022 Aug 22, 2022	BUY	$4.27 - $8.26 $201,774 - $390,318	47,254 New	47,254 $213,000

7.48M

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.